Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
63%(5 trials)

Phase Distribution

Ph not_applicable
9
75%
Ph phase_2
1
8%
Ph early_phase_1
1
8%
Ph phase_4
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(8)
Terminated(1)
Other(3)

Detailed Status

Completed8
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 41 (8.3%)
N/A9 (75.0%)

Trials by Status

unknown325%
withdrawn18%
completed867%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12